HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keith P Van Haren Selected Research

Demyelinating Diseases (Demyelinating Disease)

11/2023A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis.
4/2023A Phase 1 Study of Oral Vitamin D3 in Boys and Young Men With X-Linked Adrenoleukodystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keith P Van Haren Research Topics

Disease

2Demyelinating Diseases (Demyelinating Disease)
11/2023 - 04/2023
2Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
11/2023 - 04/2023
1Disease Progression
03/2024
1Autoimmune Diseases of the Nervous System
11/2023
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2023
1Gliosis
11/2023
1Inflammation (Inflammations)
11/2023
1Rare Diseases (Rare Disease)
01/2018

Drug/Important Bio-Agent (IBA)

1trans-crotonin (CTN)IBA
03/2024
1InflammasomesIBA
11/2023
1CuprizoneIBA
11/2023
1FibrinIBA
11/2023
1Interleukin-18 (Interleukin 18)IBA
11/2023
1Cholecalciferol (Vitamin D3)FDA Link
04/2023
125-hydroxyvitamin DIBA
04/2023
1Vitamin DFDA LinkGeneric
04/2023

Therapy/Procedure

2Immunotherapy
11/2023 - 01/2018
2Therapeutics
11/2023 - 04/2023